loader image
Close
A New Paradigm for Treating Chronic Inflammatory Disease A New Paradigm for Treating Chronic Inflammatory Disease

news

 SFA Therapeutics Invited to Present at Angel Venture Fair
0
By admin
In news
Posted October 6, 2020

SFA Therapeutics Invited to Present at Angel Venture Fair

Investors Meet Thirty of Top Startups in America-Angel Venture TUE, OCT 13 2020 9:00 AM—FRI, OCT 30 2020 4:00 PM SFA Therapeutics has been selected to present at the The 24th annual Angel Venture [...]

READ MORE
 FDA Orphan Drug Designation Granted
0
By admin
In news
Posted October 28, 2019

FDA Orphan Drug Designation Granted

The orphan drug designation will provide SFA Therapeutics with significant drug development and tax advantages as well as an expanded period of market exclusivity. Link to Press Release

READ MORE
 Overview of SFA Therapeutics
0
By admin
In news
Posted December 15, 2017

Overview of SFA Therapeutics

SFA Therapeutics’ CEO Dr Ira Spector presents an overview of the company and its platform technology SFA Overview Presentation on YouTube Introduction to SFA Liver Disease and Oncology [...]

READ MORE
 SFA Therapeutics on Money-Matters
0
By admin
In news
Posted February 13, 2017

SFA Therapeutics on Money-Matters

Interview with SFA Therapeutics CEO on Money Matters TV- Charlie Huntington of Life Sciences Pa and Kimon Hatza, Esq. of MillCrest Law, LLP talk with Ira Spector, Ph. D. CEO of SFA Therapeutics [...]

READ MORE
Stay Updated
Let’s Get Social
© 2020 sfatherapeutics. All rights reserved.
SFAtx
  • Home
  • About Us
    • Management Team and Founders
    • Scientific Advisory Board
    • Business Advisory Team
  • Our Science
  • Current Focus and Pipeline
  • Clinical Trials
    • COVID-19
    • Psoriasis
  • News
  • Contact Us
  • News Archive